Learning from error to improve the care for all - By Natalie Hirst, Fletchers Solicitors
Medical care in the UK is generally of a high standard and huge strides have been made in understanding Genetic Haemochromatosis (GH), but more work needs to be done.
This is by no means a full list (there are millions of cereals out there!) but hopefully a help to give you an idea of the iron that is added to cereals.
In 2025, researcher Maureen Ng'etich explored the diagnosis, care experiences and treatment pathways of individuals living with genetic haemochromatosis (GH) in Lincolnshire.
Haemochromatosis affects many people around the world. It is essential that those diagnosed with haemochromatosis, no matter where they live in the world, are able to access the help and support needed.
If you are a “S65C carrier” it means that you have inherited a single copy of the S65C variant from one of your parents. This is sometimes called a heterozygous carrier.
eLearning Module : treatment for genetic haemochromatosis
Venesection helps to reduce excess iron stores through a repeated process of blood removal - and the body's subsequent replacement of the blood removed.
eLearning Module : the genetics of haemochromatosis
GH is caused by the inheritance of two mutated copies of the HFE gene (meaning high ferritin) leading to increased iron absorption across the intestinal mucosa.
This guide for parents and carers explains the rare type 2 variant of genetic haemochromatosis, which typically affects young people under 25 years old.
Carrier is the term used when someone has been shown to have inherited a single copy of the HFE gene mutation from one of the parents. This is sometimes called a heterozygous carrier. Carriers might be at risk of iron loading.
At Haemochromatosis UK we have an Education Programme specifically tailored to GPs to get identify and diagnose patients with genetic haemochromatosis as well as offering support and ongoing treatment to patients already diagnosed.
This online eLearning module provides an overview of genetic haemochromatosis, including the signs, symptoms, diagnosis, treatment, and management of the condition.
While the condition is often associated with mutations in a single gene, particularly the HFE gene, recent clinical cases of digenic inheritance have been identified.
If you have a lot of great stories to tell, consider breaking them into sections, years or themes. You can then use separate posts in a listing page to bring them together (write a short intro for the listing page).
In Scotland, people with genetic haemochromatosis who are in the maintenance phase, can become blood donors through the Scottish National Blood Transfusion Service (SNBTS).